Skip to content
Search

Latest Stories

Heart attack potential factor in long-term cognitive decline: Study

The assessment encompassed various aspects of cognition, including global or overall cognition over time, as well as memory and executive functioning

Heart attack potential factor in long-term cognitive decline: Study

According to a recent study conducted by Johns Hopkins Medicine in the US, individuals who have experienced a heart attack exhibit a notably faster decline in cognitive abilities over the years following the cardiac event.

The research involved an extensive analysis of six separate large-scale studies conducted between 1971 and 2019, comparing cognitive changes in individuals who had suffered heart attacks with those who were similar in all aspects except for not having experienced a heart attack.


The results of the study have been published in the Journal of the American Medical Association (JAMA) Neurology.

"Due to the fact that many people are at risk for having a heart attack, we hope that the results of our study will serve as a wake-up call for people to control vascular risk factors like high blood pressure and elevated cholesterol as soon as they can since we have shown that having a heart attack increases your risk of decreased cognition and memory later on in life," said Michelle Johansen, an associate professor of neurology at the Johns Hopkins University School of Medicine.

A heart attack, also known as myocardial infarction, is a critical medical condition in which the blood flow to the heart is abruptly and severely restricted or blocked, leading to the death of heart muscle cells due to insufficient oxygen supply.

Although the researchers did not observe significant cognitive decline immediately after the initial heart attack, individuals who experienced a heart attack displayed a decline in cognitive test performance over the subsequent years.

The study included a sample of 30,465 individuals who had not previously experienced a heart attack, stroke, or dementia at the time of their initial cognitive assessment. Among this group, 1,033 individuals went on to suffer at least one heart attack, with 137 of them experiencing two heart attacks.

In terms of the overall sample, 29 per cent of participants were identified as Black, 8 per cent as Hispanic, and 56 per cent as women. It was observed that individuals who had experienced heart attacks tended to be older and predominantly male.

The researchers evaluated different cognitive domains of the participants by scoring various aspects of their cognition through a series of cognitive tests. These scores were then combined to represent a single cognitive domain. A decrease in points indicated a decline in that specific cognitive domain.

The assessment encompassed various aspects of cognition, including global or overall cognition over time, as well as memory and executive functioning.

Executive functioning refers to the cognitive ability to make complex decisions and carry out tasks that involve planning, problem-solving, and cognitive flexibility.

Johansen said that the next steps were to look at other aspects of heart health and how they might affect brain health.

"We have shown that preventing heart attacks may be one strategy to preserve brain health in older adults," she said.

"Now we need to determine what specifically is causing the cognitive decline over time,” she added.

(PTI)

More For You

​Dilemmas of dating in a digital world

We are living faster than ever before

AMG

​Dilemmas of dating in a digital world

Shiveena Haque

Finding romance today feels like trying to align stars in a night sky that refuses to stay still

When was the last time you stumbled into a conversation that made your heart skip? Or exchanged a sweet beginning to a love story - organically, without the buffer of screens, swipes, or curated profiles? In 2025, those moments feel rarer, swallowed up by the quickening pace of life.

Keep ReadingShow less
Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less